Shree Ganesh Biotech (India) Ltd.

Shree Ganesh Biotech (India) Ltd.

BBSE:SHREEGANES
0.44
INR
-0.02
(-4.35%)
-0.01EPS
227.22MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.46
0.58
1.42
2.15
0.15
0.06
0.43
1.82
1.57
0.51
0.58
0.12
0.13
Basic EPS, GAAP
0.09
0.15
0.62
0.96
0.04
0.01
0.01
0.06
0.05
0.02
0.01
0.01
-0.01
Free Cash Flow per Basic Share
-0.05
-0.01
-2.16
0.61
-0.01
-0.03
0.06
0.09
0.26
0.25
-0.26
-0.21
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
1.16
1.3
5.29
6.24
1.44
1.44
1.45
1.51
1.56
1.58
1.59
1.6
- -
Tangible Book Value per Share
1.16
1.3
5.29
6.24
1.44
1.44
1.45
1.51
1.56
1.58
1.59
1.6
- -
Basic Weighted Avg Shares
37
37
60
37
399
399
399
399
399
399
399
399
380
Sales/Revenue/Turnover
17
21
85
79
59
25
172
726
625
203
230
50
50
Operating Margin (%)
24.51
29.37
49.93
44.55
30.51
9.56
4.11
4.75
3.44
-0.99
-0.47
-12.88
-35.14
Depreciation Expense
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
3
5
37
35
18
2
3
25
20
6
3
4
-4
Effective Tax Rate (%)
- -
2.04
- -
- -
- -
- -
26
27.82
24.89
27.4
28.04
26.55
- -
Profit Margin (%)
20.48
25.44
43.73
44.55
30.5
9.54
1.84
3.48
3.26
3.06
1.21
7.6
-7.7
Working Capital
16
22
90
103
126
138
118
107
27
-69
32
117
- -
LT Debt
- -
- -
1
2
2
2
2
- -
- -
- -
- -
- -
- -
Total Equity
42
48
194
229
572
575
578
603
624
630
633
636
- -
Return on Invested Capital (%)
- -
10.65
30.14
16.45
4.45
0.41
0.55
4.17
2.6
-0.23
-1.09
-0.74
- -
Return on Capital (%)
- -
12.03
30.34
16.45
4.45
0.41
0.55
4.27
3.32
0.99
0.44
0.6
- -
Return on Common Equity (%)
- -
11.97
30.92
16.57
4.47
0.41
0.55
4.28
3.32
0.99
0.44
0.6
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
399
399
399
Market Capitalization
247
215
227

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
119
- -
Cash, Cash Equivalents & STI
- -
2
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
117
- -
Total Current Liabilities
- -
2
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
48.47%
1.96%
0.6%
Free Cash Flow
2,997.39%
4.49%
-19.75%
Net Income, GAAP
107.38%
117.81%
35.63%
Sales/Revenue/Turnover
98.31%
35.06%
-78.35%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
36
20
144
30
230
2026
14
8
7
21
50
2027
14
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.01
0.01
0.02
-0.02
0.01
2026
0.01
- -
0.01
- -
0.01
2027
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Aman Pravinkumar Patel
Full Time Employees
5
Sector
Process industries
Industry
Agricultural commodities/Milling
Address
Kamdhenu Building Kolkata WB India 700016
IPO Date
Nov 24, 2015
Business
I did not find specific recent information about major company changes, partnerships, funding rounds, acquisitions, or new product launches for Shree Ganesh Bio-Tech (India) Limited in the latest search results. To complement this, I will now gather detailed company profile information including main products, services, industry, geographic operations, and foundational details from its website and reliable financial databases to create a comprehensive and professional company description. I will fetch the full company profile from the company website and a financial database listing.